Inc
Biotechnology• Vancouver, Canada• Est. 2012
AbCellera Biologics Inc
Market Cap
$1500B
Stock Price
$12
ABCL
Corporate Profile
AbCellera Biologics Inc stands as a titan in the Biotechnology sector. With a valuation of $1500 Billion, the company employs over Unknown people worldwide. Headquartered in Vancouver, Canada, it continues to drive innovation and maintain its market dominance.
Financial Performance
Revenue
--
Market Cap
$1500B
Stock
$12